Cargando…

Differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humans

doi:10.1038/sj.bjc.6600503 www.bjcancer.com © (2002) Cancer Research UK

Detalles Bibliográficos
Autor principal: Malonne, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376137/
https://www.ncbi.nlm.nih.gov/pubmed/12177787
http://dx.doi.org/10.1038/sj.bjc.6600503
_version_ 1782154698780835840
author Malonne, H
author_facet Malonne, H
author_sort Malonne, H
collection PubMed
description doi:10.1038/sj.bjc.6600503 www.bjcancer.com © (2002) Cancer Research UK
format Text
id pubmed-2376137
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23761372009-09-10 Differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humans Malonne, H Br J Cancer Letter to the Editor doi:10.1038/sj.bjc.6600503 www.bjcancer.com © (2002) Cancer Research UK Nature Publishing Group 2002-08-12 /pmc/articles/PMC2376137/ /pubmed/12177787 http://dx.doi.org/10.1038/sj.bjc.6600503 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Malonne, H
Differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humans
title Differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humans
title_full Differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humans
title_fullStr Differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humans
title_full_unstemmed Differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humans
title_short Differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humans
title_sort differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humans
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376137/
https://www.ncbi.nlm.nih.gov/pubmed/12177787
http://dx.doi.org/10.1038/sj.bjc.6600503
work_keys_str_mv AT malonneh differencesinefficacyfoundinanimalsbetweenrecombinantformsoferythropoietinwillnotnecessarilytranslateintodifferencesinhumans